BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15954396)

  • 1. [Antiphospholipid syndrome].
    Atsumi T; Koike T
    Nihon Rinsho; 2005 May; 63 Suppl 5():484-9. PubMed ID: 15954396
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiphospholipid syndrome: diagnosis, pathogenesis, and management.
    Harris EN; Peirangeli SS; Gharavi AE
    J Med Assoc Ga; 2002; 91(1):31-4. PubMed ID: 11938625
    [No Abstract]   [Full Text] [Related]  

  • 3. Precision medicine and the antiphospholipid syndrome: what is the future?
    Rodriguez-Pintó I; Espinosa G; Cervera R
    Clin Rheumatol; 2020 Apr; 39(4):1015-1017. PubMed ID: 32060811
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiphospholipid syndrome and recurrent miscarriage.
    Rai RS
    J Postgrad Med; 2002; 48(1):3-4. PubMed ID: 12082317
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combined therapy in pregnancy with primary antiphospholipid syndrome].
    Szodoray P; Bacskó G; Lakos G; Zeher M
    Orv Hetil; 2003 Dec; 144(49):2411-3. PubMed ID: 14725207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of antiphospholipid antibodies].
    Atsumi T; Koike T
    Rinsho Byori; 1998 Apr; 46(4):297-302. PubMed ID: 9594618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiphospholipid syndrome].
    Yuste JR; Beloqui O; De la Peña A; Prieto J
    Rev Med Univ Navarra; 1998; 42(4):194-207. PubMed ID: 10420931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W; Matthias T; Scharrer I
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Laboratory tests for detection of antiphospholipid antibodies].
    Yasumuro Y; Taki M
    Rinsho Byori; 2001 Mar; Suppl 115():91-102. PubMed ID: 11391941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibodies.
    Triplett DA
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):726-30. PubMed ID: 16258476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
    Arnoux D; Boutière B; Sanmarco M
    Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Audit of laboratory investigation of antiphospholipid syndrome.
    Myers B; Dolan G; Gould J
    Br J Haematol; 2001 Oct; 115(1):229. PubMed ID: 11722438
    [No Abstract]   [Full Text] [Related]  

  • 14. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology of the antiphospholipid syndrome: who is at risk?
    Finazzi G
    Curr Rheumatol Rep; 2001 Aug; 3(4):271-6. PubMed ID: 11470044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assay principles of antiphospholipid antibodies and heterogeneity of the antibodies].
    Matsuura E
    Rinsho Byori; 2000 Apr; 48(4):317-22. PubMed ID: 10810876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of antiphospholipid syndrome.
    Bertolaccini ML; Khamashta MA
    Expert Rev Hematol; 2008 Dec; 1(2):183-8. PubMed ID: 21082923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin and the antiphospholipid syndrome: does one size fit all?
    Kasthuri RS; Roubey RA
    Arthritis Rheum; 2007 Dec; 57(8):1346-7. PubMed ID: 18050224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.